Furthermore, a recent meta-analysis involving 46 clinical trials encompassing nearly 12,300 patients utilizing the urine PCA3 test in the diagnosis of prostate cancer was able to reproduce these findings [17]. Here, PCA3 is linked to prostate carcinoma.